Home › Companies › Rapt Therapeutics Inc.

Rapt Therapeutics Inc. proxy voting records

How asset managers voted at Rapt Therapeutics Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.

• CUSIP issuer number75382E
• SEC CIK1673772

Recent shareholder votes

• May 29, 2025 annual meeting (2024-2025 proxy season): 6 items in Rapt Therapeutics Inc.'s official results (Form 8-K, filed May 29, 2025); lowest support 76% of votes cast (Non-Binding Advisory Vote on the Compensation of the Company's…). Full results and how funds voted.

Each line is the company’s own Form 8-K tally as shown on that season’s page; support is FOR as a share of votes cast.

Proxy seasons

Earlier seasons list this company under the name RAPT THERAPEUTICS INC., as its holders filed it.

Explore Rapt Therapeutics Inc. in the interactive database

The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. This page is rebuilt weekly; built November 9, 2026.